Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation is used to treat hemorrhoids. Off-label uses include priapism and induction of local vasoconstriction.
Department of Anesthesiology, Department of Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico; Via F. Sforza 35, Milano, Italy
Byers Eye Institute, Stanford University, Palo Alto, California, United States
F. I. Proctor Foundation, University of California, San Francisco, San Francisco, California, United States
Casey Eye Institute, Oregon Health & Science University, Portland, Oregon, United States
West Virginia University Hospital, Morgantown, West Virginia, United States
Children's Healthcare of Atlanta at Egleston, Atlanta, Georgia, United States
Children's Medical Center of Dallas, Dallas, Texas, United States
Stony Brook Medicine, Stony Brook, New York, United States
KK Women's and Children's Hospital, Singapore, Singapore
University of São Paulo, São Paulo, Brazil
Vanderbilt University, Nashville, Tennessee, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.